NO895195D0 - Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter. - Google Patents
Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter.Info
- Publication number
- NO895195D0 NO895195D0 NO895195A NO895195A NO895195D0 NO 895195 D0 NO895195 D0 NO 895195D0 NO 895195 A NO895195 A NO 895195A NO 895195 A NO895195 A NO 895195A NO 895195 D0 NO895195 D0 NO 895195D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- intermediate products
- derivatives intermediate
- piperidin derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK716088A DK716088D0 (da) | 1988-12-22 | 1988-12-22 | Reduktion af piperidin-dion-derivater samt intermediat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO895195D0 true NO895195D0 (no) | 1989-12-21 |
| NO895195L NO895195L (no) | 1990-06-25 |
Family
ID=8149232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89895195A NO895195L (no) | 1988-12-22 | 1989-12-21 | Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0374675A2 (no) |
| JP (1) | JPH02225468A (no) |
| AU (1) | AU4692889A (no) |
| CA (1) | CA2005355A1 (no) |
| DK (1) | DK716088D0 (no) |
| FI (1) | FI896096A7 (no) |
| IL (1) | IL92682A0 (no) |
| NO (1) | NO895195L (no) |
| PT (1) | PT92716A (no) |
| ZA (1) | ZA899778B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL98757A (en) * | 1990-07-18 | 1997-01-10 | Novo Nordisk As | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
| GB9209687D0 (en) * | 1992-05-06 | 1992-06-17 | Smithkline Beecham Plc | Novel process |
| GB9305175D0 (en) * | 1993-03-13 | 1993-04-28 | Smithkline Beecham Plc | Novel process |
| SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
| US6444190B2 (en) | 1995-08-03 | 2002-09-03 | Fmc Corporation | Reduction compositions and processes for making the same |
| ES2121685B1 (es) * | 1996-04-10 | 1999-09-16 | Vita Invest Sa | Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina. |
| JP3446468B2 (ja) | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | ピペリジンカルビノール類の製造方法 |
| US5936090A (en) * | 1996-05-24 | 1999-08-10 | Fmc Corporation | Processes for the reduction of imide ester functionality |
| WO1998056787A1 (en) | 1997-06-10 | 1998-12-17 | Synthon B.V. | 4-Phenylpiperidine compounds |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| IT1313702B1 (it) * | 1999-08-02 | 2002-09-09 | Chemi Spa | Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine. |
| GB9930577D0 (en) * | 1999-12-23 | 2000-02-16 | Smithkline Beecham Plc | Novel process |
-
1988
- 1988-12-22 DK DK716088A patent/DK716088D0/da not_active Application Discontinuation
-
1989
- 1989-12-11 EP EP89122827A patent/EP0374675A2/en not_active Withdrawn
- 1989-12-13 IL IL92682A patent/IL92682A0/xx unknown
- 1989-12-13 CA CA002005355A patent/CA2005355A1/en not_active Abandoned
- 1989-12-18 AU AU46928/89A patent/AU4692889A/en not_active Abandoned
- 1989-12-19 FI FI896096A patent/FI896096A7/fi not_active Application Discontinuation
- 1989-12-20 ZA ZA899778A patent/ZA899778B/xx unknown
- 1989-12-21 NO NO89895195A patent/NO895195L/no unknown
- 1989-12-22 PT PT92716A patent/PT92716A/pt not_active Application Discontinuation
- 1989-12-22 JP JP1331427A patent/JPH02225468A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0374675A2 (en) | 1990-06-27 |
| PT92716A (pt) | 1990-06-29 |
| ZA899778B (en) | 1990-09-26 |
| NO895195L (no) | 1990-06-25 |
| FI896096A0 (fi) | 1989-12-19 |
| CA2005355A1 (en) | 1990-06-22 |
| FI896096A7 (fi) | 1990-06-23 |
| IL92682A0 (en) | 1990-09-17 |
| JPH02225468A (ja) | 1990-09-07 |
| DK716088D0 (da) | 1988-12-22 |
| AU4692889A (en) | 1990-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904987D0 (no) | Fremgangsmaate for fremstilling av indolderivater. | |
| NO892936L (no) | Fremgangsmaate for fremstilling av furanderivater. | |
| NO903431L (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO895195D0 (no) | Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter. | |
| NO880910D0 (no) | Fremgangsmaate for fremstilling av chromonderivater. | |
| NO903275L (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO905377L (no) | Fremgangsmaate for fremstilling av glycerolderivater. | |
| NO903043D0 (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO884900L (no) | Fremgangsmaate for fremstilling av ginkolid-derivater. | |
| NO891588L (no) | Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater. | |
| NO903207D0 (no) | Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater. | |
| NO883145D0 (no) | Fremgangsmaate til fremstilling av tienoimidazolderivater. | |
| NO902762D0 (no) | Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater. | |
| NO894707L (no) | Fremgangsmaate for fremstilling av benzoksazinderivater. | |
| NO884100L (no) | Fremgangsmaate for fremstilling av halogentiazolderivater. | |
| NO883398D0 (no) | Fremgangsmaate for fremstilling av benzoksazinderivater. | |
| NO892813D0 (no) | Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater. | |
| NO905047L (no) | Fremgangsmaate for fremstilling av selenofenderivater. | |
| NO903254D0 (no) | Fremgangsmaate for fremstilling av kinuklidin-derivater. | |
| NO871521L (no) | Fremgangsmaate for fremstilling av benzoksa- henholdsvis benzotia-diazolderivater. | |
| NO904362D0 (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO922254L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater | |
| NO922253L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater | |
| NO883526D0 (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. | |
| NO883525L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. |